S Salloway Selected Research

Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)

7/2007

Galantamine treatment of vascular dementia: a randomized trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Salloway Research Topics

Disease

12	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 11/2002
5	Cognitive Dysfunction 01/2023 - 08/2004
5	Dementia (Dementias) 01/2023 - 01/2001
2	Hemorrhage 01/2023 - 01/2021
2	Edema (Dropsy) 10/2013 - 12/2009
1	Seizures (Absence Seizure) 01/2022
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 07/2007

Drug/Important Bio-Agent (IBA)

6	Amyloid (Amyloid Fibrils)IBA 01/2023 - 09/2011
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2011
2	aducanumabIBA 01/2022 - 01/2021
2	Apolipoproteins E (ApoE)IBA 12/2009 - 11/2002
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 05/2009 - 08/2004
1	AnticoagulantsIBA 01/2023
1	lecanemabIBA 01/2023
1	HemosiderinIBA 10/2013
1	scyllitol (scyllo-inositol)IBA 09/2011
1	bapineuzumabIBA 12/2009
1	Monoclonal AntibodiesIBA 12/2009
1	Amyloid beta-PeptidesIBA 12/2009
1	Galantamine (Galanthamine)FDA LinkGeneric 07/2007
1	Donepezil (Aricept)FDA LinkGeneric 08/2004
1	Apolipoprotein E4IBA 11/2002

Therapy/Procedure

3	Activities of Daily Living (ADL) 09/2011 - 01/2001
2	Therapeutics 01/2020 - 01/2019
1	Immunotherapy 01/2018